+1 347 708 0418
Inflammatory Bowel Disease (IBD) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease (IBD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
AbbVie
Pfizer
Takeda
Janssen Biotech
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 TNF Inhibitors
1.2.3 Aminosalicyclates
1.2.4 Immunomodulators
1.2.5 Corticosteroids
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2017-2028)
2.2 Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Region
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Inflammatory Bowel Disease (IBD) Treatment Market Dynamics
2.3.1 Inflammatory Bowel Disease (IBD) Treatment Industry Trends
2.3.2 Inflammatory Bowel Disease (IBD) Treatment Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Treatment Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2021
3.5 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2023-2028)
5 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2017-2028)
6.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
6.2.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022)
6.2.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028)
6.2.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2017-2028)
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
6.3.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022)
6.3.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028)
6.3.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2017-2028)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
6.4.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022)
6.4.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2017-2028)
7.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
7.2.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2017-2028)
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
7.3.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2017-2028)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
7.4.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
8.2.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
8.3.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region
8.4.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size (2017-2028)
9.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
9.2.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2017-2028)
9.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
9.3.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2017-2028)
9.4 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
9.4.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
10.2.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
10.3.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
10.4.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
11.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.1.5 AbbVie Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
11.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
11.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.3.5 Takeda Recent Developments
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Introduction
11.4.4 Janssen Biotech Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.4.5 Janssen Biotech Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
11.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
11.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.6.5 Bausch Health Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.7.5 Takeda Pharmaceutical Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
11.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Inflammatory Bowel Disease (IBD) Treatment Introduction
11.9.4 Biogen Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
11.9.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of Aminosalicyclates
Table 4. Key Players of Immunomodulators
Table 5. Key Players of Corticosteroids
Table 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2017-2022)
Table 10. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2023-2028)
Table 12. Inflammatory Bowel Disease (IBD) Treatment Market Trends
Table 13. Inflammatory Bowel Disease (IBD) Treatment Market Drivers
Table 14. Inflammatory Bowel Disease (IBD) Treatment Market Challenges
Table 15. Inflammatory Bowel Disease (IBD) Treatment Market Restraints
Table 16. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Inflammatory Bowel Disease (IBD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2021)
Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
Table 23. Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Application (2017-2022)
Table 31. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Application (2023-2028)
Table 33. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Inflammatory Bowel Disease (IBD) Treatment Product
Table 66. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 67. AbbVie Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Inflammatory Bowel Disease (IBD) Treatment Product
Table 71. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Inflammatory Bowel Disease (IBD) Treatment Product
Table 76. Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 77. Takeda Recent Developments
Table 78. Janssen Biotech Company Details
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Product
Table 81. Janssen Biotech Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 82. Janssen Biotech Recent Developments
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Inflammatory Bowel Disease (IBD) Treatment Product
Table 86. Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 87. Allergan Recent Developments
Table 88. Bausch Health Company Details
Table 89. Bausch Health Business Overview
Table 90. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Product
Table 91. Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 92. Bausch Health Recent Developments
Table 93. Takeda Pharmaceutical Company Details
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product
Table 96. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 97. Takeda Pharmaceutical Recent Developments
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Inflammatory Bowel Disease (IBD) Treatment Product
Table 101. Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 102. Novartis Recent Developments
Table 103. Biogen Company Details
Table 104. Biogen Business Overview
Table 105. Biogen Inflammatory Bowel Disease (IBD) Treatment Product
Table 106. Biogen Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022) & (US$ Million)
Table 107. Biogen Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. TNF Inhibitors Features
Figure 3. Aminosalicyclates Features
Figure 4. Immunomodulators Features
Figure 5. Corticosteroids Features
Figure 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Inflammatory Bowel Disease (IBD) Treatment Report Years Considered
Figure 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Inflammatory Bowel Disease (IBD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players in 2021
Figure 15. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2021
Figure 17. North America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Region (2017-2028)
Figure 37. China Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 58. Takeda Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 59. Janssen Biotech Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 60. Allergan Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 61. Bausch Health Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 64. Biogen Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Buy
